| Phase I trial of olaparib (PARP inhibitor) and vistusertib (mTORC1/2 inhibitor) in recurrent endometrial, ovarian and triple negative breast cancer. SN Westin, JK Litton, RA Williams, CJ Shepherd, W Brugger, EJ Pease, ... Journal of Clinical Oncology 36 (15_suppl), 5504-5504, 2018 | 28 | 2018 |
| A pilot study of neoadjuvant talazoparib for early-stage breast cancer patients with a BRCA mutation JK Litton, M Scoggins, DL Ramirez, RK Murthy, GJ Whitman, KR Hess, ... Annals of Oncology 27, vi46, 2016 | 21 | 2016 |
| Phase I expansion of olaparib (PARP inhibitor) and AZD5363 (AKT inhibitor) in recurrent ovarian, endometrial and triple negative breast cancer S Westin, J Litton, R Williams, P Soliman, M Frumovitz, K Schmeler, ... Annals of Oncology 28, v130-v131, 2017 | 14 | 2017 |
| A phase II trial of olaparib and durvalumab in metastatic BRCA wild type triple-negative breast cancer. ZI Mitri, J Vuky, KA Kemmer, MA Savin, S Parmar, AK Kolodzie, ... Journal of Clinical Oncology 37 (15_suppl), TPS1111-TPS1111, 2019 | 10 | 2019 |
| Pushing the bar in treatment of cervical cancer: what can comprehensive cancer centers do on their own? DS Dizon, TCCSI Group Gynecologic Oncology 131 (2), 464-466, 2013 | 6 | 2013 |
| Managing bacterial diseases with programs including a premix fungicide containing famoxadone and cymoxanil M Martin, C Shepherd, R Williams, S Smith, R Armstrong Phytopathology 95 (6), 2005 | 1 | 2005 |
| Abstract LB010: SMMART Program: A multi-omics tumor board with a focus on breast cancer BL Kong, BE Johnson, JM Keck, S Mitri, P Leyshock, JM Stommel, K Siex, ... Cancer Research 81 (13_Supplement), LB010-LB010, 2021 | | 2021 |
| Field test and validation of the Multiplier measles, mumps, rubella, and varicella-zoster multiplexed assay system in the Democratic Republic of the Congo by using dried blood … SG Higgins, NA Hoff, A Gadoth, A Fusellier, P Mukadi, V Alfonso, ... | | 2019 |
| Animal studies F Wang, Y Li, Z Yang, K Lu, J Zuo, Z Zhou, TR Fosnight, FM Hooi, RD Keil, ... Ultrasound in Medicine and Biology 43, 2017 | | 2017 |
